Cassandra Gilmour

机构：Translational Research in Oncology · ORCID：0000-0003-4885-2862

发表论文 15 篇 · 总被引 93 次 · h-index 2

代表论文

• Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors (2023 · Frontiers in Immunology · 被引 47)
• LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses (2024 · Science Immunology · 被引 43)
• Abstract PR02: The co-expression of VISTA and TIGIT on cytotoxic T cells defines subpopulation with altered immunometabolism (2022 · Cancer Immunology Research · 被引 2)
• Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 1)
• T cell–intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responses (2026 · Journal of Clinical Investigation)
• Patient-informed CRISPR screening reveals gene targets to improve CAR T-cell efficacy (2025 · Blood)